Herrmann, H., Cerny-Reiterer, S., Gleixner, K. V., Blatt, K., Herndlhofer, S., Rabitsch, W., . . . Valent, P. (2012). CD34(+)/CD38(−) stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicin. Ferrata Storti Foundation.
Chicago Style CitationHerrmann, Harald, et al. CD34(+)/CD38(−) Stem Cells in Chronic Myeloid Leukemia Express Siglec-3 (CD33) and Are Responsive to the CD33-targeting Drug Gemtuzumab/ozogamicin. Ferrata Storti Foundation, 2012.
MLA CitationHerrmann, Harald, et al. CD34(+)/CD38(−) Stem Cells in Chronic Myeloid Leukemia Express Siglec-3 (CD33) and Are Responsive to the CD33-targeting Drug Gemtuzumab/ozogamicin. Ferrata Storti Foundation, 2012.
Warning: These citations may not always be 100% accurate.